China Economic Network, Beijing, March 8 (Reporter Yang Xiufeng) Traditional Chinese medicine is the crystallization of thousands of years of health and wellness concepts of the Chinese nation, and is a treasure of Chinese civilization. This year's government work report mentioned promoting the inheritance, innovation and development of traditional Chinese medicine. "This not only points out the direction for the development of traditional Chinese medicine, but also reflects the high expectations for the development of traditional Chinese medicine." Lu Qingguo, a representative of the National People's Congress and chairman and general manager of Chenguang Biotechnology Group Co., Ltd., said in an interview with a reporter from China Economic Network.

Lu Qingguo, deputy to the National People's Congress and chairman and general manager of Chenguang Biotechnology Group Co., Ltd. (Photographs provided by respondents)

"During my research, I found that in the domestic market for traditional Chinese medicinal materials, there are many differences in the quality and price of the same type of traditional Chinese medicinal materials from different origins and different qualities. The judgment on the quality of traditional Chinese medicinal materials is mostly based on the concept of 'genuine medicinal materials', focusing on the appearance of no quantitative judgment standard, and good medicinal materials cannot be sold at a good price. This has led to the phenomenon of many drug farmers emphasizing production over quality, resulting in poor quality of medicinal materials, poor efficacy of traditional Chinese medicine, and lack of treatment or obvious effects when eating traditional Chinese medicine." ", directly restricting the rapid and healthy development of the traditional Chinese medicine industry." The representative of Lu Qingguo said, "I suggest that the standards for the content of active ingredients in traditional Chinese medicine and traditional Chinese medicine be significantly increased through the revision of the pharmacopoeia as soon as possible, so as to promote the inheritance, innovation, and development of traditional Chinese medicine."

The representative of Lu Qingguo explained that the pharmacopoeia is the judgment standard for Chinese medicinal materials and traditional Chinese patent medicines and simple preparations. In recent years, the content index of some main ingredients of Chinese medicine has been gradually added in the revision of the pharmacopoeia, but there are still broad and low standards, which cannot open up the quality gap between Chinese medicinal materials and Chinese medicine, and cannot limit the entry of low-quality Chinese medicine and encourage the expansion of high-quality Chinese medicine.

"I suggest that we focus on starting the revision of the pharmacopoeia." Lu Qingguo, the representative of China, told reporters that for example, for the effective ingredient content standards of Chinese medicinal materials, we can select several representative main ingredients, and use the indicators of genuine medicinal materials with medium quality or above as the reference standard, significantly improving the existing pharmacopoeia standards, and gradually increasing and improving the component content indicators. The implementation of the new pharmacopoeia standards can set up a transitional period of several years, gradually guiding the development of traditional Chinese medicine cultivation to advantageous production areas, squeezing out production areas that are not suitable for traditional Chinese medicine cultivation, continuously improving the quality and effective ingredient content of traditional Chinese medicine, ensuring the efficacy of traditional Chinese medicine, and promoting the healthy development of China's traditional Chinese medicine industry and industry.